Biotechnology · Healthcare
Board Member
2022-04-25–present
Board Member
Compass Therapeutics, Inc. (CMPX)Equibles does not estimate personal net worth.
Get an email with a short summary when Compass Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CMPX alertsEllen Chiniara is recorded as Board Member at Compass Therapeutics, Inc. (CMPX) since April 25, 2022. Compass Therapeutics, Inc. reported in an 8-K filed April 26, 2022 that Ellen Chiniara was appointed director, effective April 25, 2022. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas J. Schuetz (CEO and Board Member), Thomas Schuetz (CEO and Board Member), Thomas Schuetz, MD, PhD (CEO and Chairman) and 7 others.
“On April 25, 2022, the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”) appointed two new directors to its Board: Ellen Chiniara, J.D., former Chief Legal Officer of Alexion Pharmaceuticals; and Mary Ann Gray, Ph.D., President of Gray Strategic Advisors.”
2022-04-25–present
Biotechnology · Healthcare
Board Member
2022-04-25–present